GB884827A - New sulphonamides - Google Patents

New sulphonamides

Info

Publication number
GB884827A
GB884827A GB30525/59A GB3052559A GB884827A GB 884827 A GB884827 A GB 884827A GB 30525/59 A GB30525/59 A GB 30525/59A GB 3052559 A GB3052559 A GB 3052559A GB 884827 A GB884827 A GB 884827A
Authority
GB
United Kingdom
Prior art keywords
hydrogen
salts
pyridazine
alkyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB30525/59A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba AG filed Critical Ciba AG
Publication of GB884827A publication Critical patent/GB884827A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention comprises sulphonamides of the formula <FORM:0884827/IV (b)/1> and salts thereof, in which R1 is hydrogen, C1-6 alkyl, halogen (e.g. Cl) or a free or etherified hydroxy group and Z1 and Z2 are hydrogen atoms or one is hydrogen and the other a C1-6 alkyl radical. The compounds are prepared by reacting together compounds of the formulae <FORM:0884827/IV (b)/2> wherein one of X1 and Y1 represents an amino group and the other a halogen atom, for example by reacting a toluenesulphonyl chloride with a pyridazine amine. Specified products include 3-chloro-, 3-hydroxy-, 3-methoxy- and 3-ethoxy-, 6 - p - toluenesulphonamido - pyridazine and 3 - chloro - 6 - benzenesulphonamido- and - 6 - o - toluenesulphonamido - pyridazine.ALSO:Pharmaceutical preparations for treatment of diseases of the liver comprise a sulphonamide of the formula <FORM:0884827/VI/1> or a salt thereof, in which R1 is hydrogen, C1-6 alkyl, halogen (e.g. Cl) or a free or etherified hydroxy group and Z1 and Z2 are hydrogen atoms or one is hydrogen and the other a C1-6 alkyl radical (see Group IV (b)) in admixture or conjunction with a pharmaceutical carrier for enteral or parenteral administration. The preparations suitably take the form of tablets, dragees, solutions, suspensions or emulsions and may contain, in addition to conventional diluents, preserving, stabilizing, wetting or emulsifying agents, salts for controlling osmotic pressure or buffer substances, or further therapeutically useful substances. Specified salts are those of alkali and alkaline-earth metals.
GB30525/59A 1958-09-05 1959-09-07 New sulphonamides Expired GB884827A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH884827X 1958-09-05

Publications (1)

Publication Number Publication Date
GB884827A true GB884827A (en) 1961-12-20

Family

ID=4545186

Family Applications (1)

Application Number Title Priority Date Filing Date
GB30525/59A Expired GB884827A (en) 1958-09-05 1959-09-07 New sulphonamides

Country Status (1)

Country Link
GB (1) GB884827A (en)

Similar Documents

Publication Publication Date Title
MY101614A (en) Improvements in or relating to benzothiophene derivatives as antiasthmatic agents
GB970886A (en) New pyridines and process for the manufacture thereof
GB1155936A (en) Novel Sulphonamides and a Process for the Manufacture thereof
GB989013A (en) New guanidines and process for their manufacture
GB884827A (en) New sulphonamides
GB826640A (en) New pyridazone compounds and process for their manufacture
GB1338985A (en) N-acyl-biscarbamates and herbicidal preparations containing them
GB927288A (en) 1-and 7-(basically-substituted-alkyl) xanthine derivatives, a process for their manufacture and pharmaceutical compositions containing them
GB729891A (en) New 4,5-dihydro-1,3,4-oxadiazol-5-one derivatives
GB1249538A (en) Adenosine derivatives
ES264827A1 (en) Novel sulphonamides and a process for the manufacture thereof
GB1153487A (en) Carboxymethyldithiocarbarmic Acids
GB1017450A (en) 2-amino-4-alkoxy-úË-triazines
GB1005021A (en) Naphthalene derivatives
GB1067694A (en) A process for the preparation of 2-alkyl-4-alkylamino-6-alkoxy-s-triazines
GB746051A (en) S:s-diethyldithioterephthalate and therapeutic compositions containing the same
GB1199758A (en) Arylsulphonyl-Semicarbazides and their production
GB1069411A (en) Naphthalene derivatives
GB1058403A (en) Improvements in or relating to novel 4-aza-thiaxanthene derivatives
GB844114A (en) Improvements in or relating to sulphonyl derivatives
GB938727A (en) Sulphonamides
GB895625A (en) New benzene-sulphonyl benzyl-ureas and process of preparing them
GB853402A (en) Steroid compounds and their preparation
GB914929A (en) Novel sulphonamides and a process for the manufacture thereof
GB1018106A (en) 2-amino-4-alkoxy-6-(4-phenylpiperazino)-alkyl-ú¾-triazines